IL2RA and cancer: Differentially methylated genes between responders and non-responders were associated with several molecular pathways, including axon guidance (e.g., BMPR1B, CAMK2D, EPHNA6, NTNG1), hippo signaling (AFP, BMP7, GLI 1), pathways in cancer (IL2RA, MAPK10, IGF1R, AKT3, MLH1, COL4A1), and MAP signaling (e.g., TAOK3, STK3, IL1RAP, MAP3K1).